Literature DB >> 12351637

Functional ATPase activity of p97/valosin-containing protein (VCP) is required for the quality control of endoplasmic reticulum in neuronally differentiated mammalian PC12 cells.

Taeko Kobayashi1, Keiko Tanaka, Kiyoshi Inoue, Akira Kakizuka.   

Abstract

Abnormal protein accumulation and cell death with cytoplasmic vacuoles are hallmarks of several neurodegenerative disorders. We previously identified p97/valosin-containing protein (VCP), an AAA ATPase with two conserved ATPase domains (D1 and D2), as an interacting partner of the Machado-Joseph disease (MJD) protein with expanded polyglutamines that causes Machado-Joseph disease. To reveal its pathophysiological roles in neuronal cells, we focused on its ATPase activity. We constructed and characterized PC12 cells expressing wild-type p97/VCP and p97(K524A), a D2 domain mutant. The expression level, localization, and complex formation of both proteins were indistinguishable, but the ATPase activity of p97(K524A) was much lower than that of the wild type. p97(K524A) induced cytoplasmic vacuoles that stained with an endoplasmic reticulum (ER) marker, and accumulation of polyubiquitinated proteins in the nuclear and membrane but not cytoplasmic fractions was observed, together with the elevation of ER stress markers. These results show that p97/VCP is essential for degrading membrane-associated ubiquitinated proteins and that profound deficits in its ATPase activity severely affect ER quality control, leading to abnormal ER expansion and cell death. Excessive accumulation of misfolded proteins may inactivate p97/VCP in several neurodegenerative disorders, eventually leading to the neurodegenerations.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12351637     DOI: 10.1074/jbc.M207783200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  58 in total

1.  ATP-binding sites in brain p97/VCP (valosin-containing protein), a multifunctional AAA ATPase.

Authors:  Ran Zalk; Varda Shoshan-Barmatz
Journal:  Biochem J       Date:  2003-09-01       Impact factor: 3.857

2.  Liver cytochrome P450 3A endoplasmic reticulum-associated degradation: a major role for the p97 AAA ATPase in cytochrome P450 3A extraction into the cytosol.

Authors:  Poulomi Acharya; Mingxiang Liao; Juan C Engel; Maria Almira Correia
Journal:  J Biol Chem       Date:  2010-11-24       Impact factor: 5.157

3.  The p97/VCP ATPase is critical in muscle atrophy and the accelerated degradation of muscle proteins.

Authors:  Rosanna Piccirillo; Alfred L Goldberg
Journal:  EMBO J       Date:  2012-07-06       Impact factor: 11.598

4.  p97 functions as an auxiliary factor to facilitate TM domain extraction during CFTR ER-associated degradation.

Authors:  Eric J Carlson; David Pitonzo; William R Skach
Journal:  EMBO J       Date:  2006-09-14       Impact factor: 11.598

5.  Involvement of the p97-Ufd1-Npl4 complex in the regulated endoplasmic reticulum-associated degradation of inositol 1,4,5-trisphosphate receptors.

Authors:  Kamil J Alzayady; Margaret M Panning; Grant G Kelley; Richard J H Wojcikiewicz
Journal:  J Biol Chem       Date:  2005-08-15       Impact factor: 5.157

6.  The slow Wallerian degeneration protein, WldS, binds directly to VCP/p97 and partially redistributes it within the nucleus.

Authors:  Heike Laser; Laura Conforti; Giacomo Morreale; Till G M Mack; Molly Heyer; Jane E Haley; Thomas M Wishart; Bogdan Beirowski; Simon A Walker; Georg Haase; Arzu Celik; Robert Adalbert; Diana Wagner; Daniela Grumme; Richard R Ribchester; Markus Plomann; Michael P Coleman
Journal:  Mol Biol Cell       Date:  2005-12-21       Impact factor: 4.138

7.  Pre-B-cell leukemia transcription factor 1 regulates expression of valosin-containing protein, a gene involved in cancer growth.

Authors:  Ying Qiu; Yasuhiko Tomita; Binglin Zhang; Itsuko Nakamichi; Eiichi Morii; Katsuyuki Aozasa
Journal:  Am J Pathol       Date:  2007-01       Impact factor: 4.307

8.  VCP/p97 AAA-ATPase does not interact with the endogenous wild-type cystic fibrosis transmembrane conductance regulator.

Authors:  Rebecca F Goldstein; Ashutosh Niraj; Todd P Sanderson; Landon S Wilson; Andras Rab; Helen Kim; Zsuzsa Bebok; James F Collawn
Journal:  Am J Respir Cell Mol Biol       Date:  2007-02-01       Impact factor: 6.914

9.  HDAC6-p97/VCP controlled polyubiquitin chain turnover.

Authors:  Cyril Boyault; Benoit Gilquin; Yu Zhang; Vladimir Rybin; Elspeth Garman; Wolfram Meyer-Klaucke; Patrick Matthias; Christoph W Müller; Saadi Khochbin
Journal:  EMBO J       Date:  2006-06-29       Impact factor: 11.598

10.  Mass spectrometric analysis of type 1 inositol 1,4,5-trisphosphate receptor ubiquitination.

Authors:  Danielle A Sliter; Kazuishi Kubota; Donald S Kirkpatrick; Kamil J Alzayady; Steven P Gygi; Richard J H Wojcikiewicz
Journal:  J Biol Chem       Date:  2008-10-27       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.